This is according to Pharmako Biotechnologies and MGC Pharmaceuticals, which discussed the importance of using the right delivery systems in this episode of Nutrition Asia.
Both companies have developed curcumin in unconventional forms. In the case of Pharmako Biotechnologies, the company has developed HydroCurc, a high bioavailability curcumin formulated using a proprietary technology called LipiSperse.
With this, the company has helped brand owners develop curcumin supplements in stick sachets, ready-to-drink sports recovery drink, and even aloe-vera juice, co-founder and commercial director Eric Meppem told us.
“We have customers here in Australia and overseas who put it into stick sachets, where people can mix it with water or directly into the mouth, which you couldn’t do with normal curcumin.
“We now have customers who ask if we can put it into effervescent tablets in the USA,” Meppem said.
As for MGC Pharmaceuticals, the company and Swiss PharmaCann have developed ArtemiC, a curcumin and artemisinin-based oral spray. A patented delivery system known as MyCell is used to increase the bioavailability of the ingredients.
The formulation, which also contains vitamin C and Boswellia serrata, is been trialled on COVID-19 patients in reducing the symptoms of the illness.
“It is based on a technology called the MyCell technology, which is the delivery method to take oil-lipid or hydrophilic substance and to put it inside a hydrophobic carrier that allows to increase the bioavailability of the substances and make it water-soluble,” Roby Zomer, co-founder and MD said.
Watch the video to find out more.
